Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Prestige Consumer Healthcare (PBH) Acquisitions (2016 - 2022)

Prestige Consumer Healthcare has reported Acquisitions over the past 5 years, most recently at $132000.0 for Q1 2022.

For Q1 2022, Acquisitions changed N/A year-over-year to $132000.0; the TTM value through Mar 2023 reached $18.1 million, changed 0.0%, while the annual FY2022 figure was $247.0 million, N/A changed from the prior year.
Acquisitions for Q1 2022 was $132000.0 at Prestige Consumer Healthcare, down from $18.0 million in the prior quarter.
Over five years, Acquisitions peaked at $18.0 million in Q4 2021 and troughed at $132000.0 in Q1 2022.